Bluejay Diagnostics Corp (BJDX): Price-to-Revenue Ratio

Corporate company logo of Bluejay Diagnostics Inc (BJDX)

Bluejay Diagnostics (BJDX) generates revenue through the sale of portable analyzers and high-margin cartridges. The company's price-to-sales ratio reflects the market valuation of the business, where the 28.50 level serves as a critical benchmark. Growth is protected by Symphony patents, although the FDA is slowing expansion. Meanwhile, the company is implementing eco-friendly testing systems and strictly adhering to bioethical standards for data storage.

P/S Multiple: Bluejay (BJDX) for 08/01/2022 - 09/02/2023

Analytical breakdowns for Bluejay (BJDX)

- current price and projected stock value:
Price Chart bluejaydx.com|BJDX - Price Target Chart
- stock exchange capitalization data:
Market Value Bluejay|BJDX - Real Price to Acquire Entire Company
- issuer book value statistics:
Book Value per Share Bluejay Diagnostics|BJDX - Book Capitalization|Market-to-Book Ratio bluejaydx.com|BJDX - Aggregate Company Assets
- business debt structure and liquidity details:
Aggregate Debt to Capital Bluejay Diagnostics|BJDX - Long-Term Debt to Capital|Short-Term Debt to Capital Bluejay Diagnostics Corp|BJDX - Company Total Debt|Debts to Book Value Bluejay|BJDX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Bluejay Diagnostics|Immediate Liquidity Ratio bluejaydx.com
- company profitability and valuation multiples indicators:
BJDX - Net Profit|Company Profit Forecast Bluejay Diagnostics|BJDX - P/E Multiple|Forward P/E Multiple Bluejay Diagnostics Inc|BJDX - PEG Multiple|Enterprise Value to EBITDA Multiple Bluejay|BJDX - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Bluejay Diagnostics|BJDX - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months bluejaydx.com|BJDX - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Bluejay Diagnostics
- issuer revenue and sales details:
BJDX - Company Sales|Company Projected Revenue Volume bluejaydx.com|BJDX - P/S Multiple|Market Cap to Expected Sales Ratio Bluejay
Summary company analytics:BJDX - bluejaydx.com
Brand item of Bluejay

Bluejay Diagnostics (BJDX) seeks to solidify its position in the rapid testing segment, countering the expansion of laboratory diagnostics behemoths by validating the accuracy of its developments. The ratio of market capitalization to annual revenue, reflected via the P/S coefficient, allows for an assessment of the premium investors are willing to pay for every dollar of sales, making this chart a tool for finding the balance between risk and potential return.

Who Bluejay Diagnostics competes with

Price-to-Revenue Ratio A (agilent.com)|Price-to-Revenue Ratio Quest Diagnostics Incorporated DGX|Illumina Inc - Price-to-Revenue Ratio|EXAS: Market Cap to Revenue|RVTY - P/S Multiple|BIO: P/S Multiple|Price to Sales anbio.com (NNNN)|Price-to-Revenue Ratio Sotera Health|QDEL (Quidel Corporation) - Market Cap to Sales Volume|P/S Multiple OPK|P/S Multiple CareDx Health (CDNA)|Maravai LifeSciences - Market Cap to Revenue|fulgentgenetics.com (FLGT) - Price to Sales|LAB: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio CTKB (Cytek Biosciences Inc)|OSUR: P/S Multiple|Market Cap to Revenue Ratio XGN|MDXH (MDxHealth SA) - P/S Multiple|luciddx.com (LUCD) - Price-to-Revenue Coefficient|P/S Multiple PRE|P/S Multiple imdxinc.com (IMDX)|P/S Multiple TRIB (Trinity Biotech)|Price-to-Revenue Multiple ProPhase Labs Corp|AIMD - Price-to-Revenue Ratio|CODX (codiagnostics.com) - Market Cap to Revenue Ratio|HeartSciences (HSCS) - Price-to-Revenue Ratio|Price to Sales Biomerica Inc. (BMRA)|Price-to-Revenue Ratio Cardio Diagnostics Holdings Inc.|Onconetix Corporation (ONCO) - Price-to-Revenue Coefficient|Market Cap to Revenue VRAX (Virax Biolabs Group)|Market Cap to Sales Volume AWH|P/S Multiple AXDX (Accelerate Diagnostics, Inc.)|Price-to-Revenue Coefficient Centogene N.V. (CNTG)|Enzo - P/S Multiple|Fresh2 Group Limited (FRES) - Market Cap to Revenue|gtglabs.com (GENE) - Price-to-Revenue Ratio|ME - Price-to-Revenue Coefficient|PMD (Psychemedics Corporation) - P/S Multiple